A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 967,226 shares of ABT stock, worth $111 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
967,226
Previous 984,178 1.72%
Holding current value
$111 Million
Previous $102 Million 7.83%
% of portfolio
0.34%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $1.7 Million - $2 Million
-16,952 Reduced 1.72%
967,226 $110 Million
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $1.31 Million - $1.47 Million
-13,030 Reduced 1.31%
984,178 $102 Million
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $964,871 - $1.07 Million
-8,810 Reduced 0.88%
997,208 $113 Million
Q4 2023

Jan 24, 2024

SELL
$90.19 - $110.4 $1.41 Million - $1.72 Million
-15,604 Reduced 1.53%
1,006,018 $111 Million
Q3 2023

Oct 23, 2023

SELL
$95.53 - $114.62 $2.34 Million - $2.81 Million
-24,546 Reduced 2.35%
1,021,622 $98.9 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $1.36 Million - $1.52 Million
-13,519 Reduced 1.28%
1,046,168 $114 Million
Q1 2023

May 17, 2023

BUY
$96.86 - $114.01 $99.6 Million - $117 Million
1,028,505 Added 3298.39%
1,059,687 $107 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $98.7 Million - $116 Million
-1,019,447 Reduced 97.03%
31,182 $3.16 Billion
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $6.5 Million - $7.63 Million
-68,387 Reduced 6.11%
1,050,629 $115 Million
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $1.34 Million - $1.55 Million
13,841 Added 1.25%
1,119,016 $108 Million
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $723,676 - $874,693
-7,090 Reduced 0.64%
1,105,175 $120 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $131,921 - $160,869
1,157 Added 0.1%
1,112,265 $132 Million
Q4 2021

Jan 31, 2022

SELL
$115.53 - $141.46 $3.2 Million - $3.92 Million
-27,694 Reduced 2.43%
1,111,108 $156 Million
Q3 2021

Oct 20, 2021

SELL
$116.66 - $129.06 $5.24 Million - $5.79 Million
-44,874 Reduced 3.79%
1,138,802 $135 Million
Q2 2021

Jul 20, 2021

SELL
$105.79 - $124.53 $5.98 Million - $7.04 Million
-56,495 Reduced 4.56%
1,183,676 $137 Million
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $7.43 Million - $8.75 Million
-68,264 Reduced 5.22%
1,240,171 $149 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $6.16 Million - $6.71 Million
-58,649 Reduced 4.29%
1,308,435 $143 Million
Q3 2020

Nov 06, 2020

SELL
$91.64 - $111.29 $10.6 Million - $12.8 Million
-115,137 Reduced 7.77%
1,367,084 $149 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $6.01 Million - $7.69 Million
-78,483 Reduced 5.03%
1,482,221 $136 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $430,945 - $630,159
6,860 Added 0.44%
1,560,704 $123 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $140,061 - $155,921
-1,784 Reduced 0.11%
1,553,844 $135 Million
Q3 2019

Nov 20, 2019

BUY
$81.84 - $88.74 $92,561 - $100,364
1,131 Added 0.07%
1,555,628 $130 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $56,992 - $66,470
-782 Reduced 0.05%
1,554,497 $131 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $1.18 Million - $1.42 Million
17,793 Added 1.16%
1,555,279 $124 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $1.83 Million - $2.08 Million
-27,948 Reduced 1.79%
1,537,486 $111 Million
Q3 2018

Oct 23, 2018

SELL
$60.81 - $73.36 $2.04 Million - $2.46 Million
-33,572 Reduced 2.1%
1,565,434 $115 Million
Q2 2018

Aug 02, 2018

BUY
$57.57 - $63.54 $209,036 - $230,713
3,631 Added 0.23%
1,599,006 $97.5 Million
Q1 2018

Apr 10, 2018

SELL
$56.27 - $63.62 $1.95 Million - $2.21 Million
-34,662 Reduced 2.13%
1,595,375 $95.6 Million
Q4 2017

Jan 22, 2018

SELL
$53.68 - $57.47 $217,833 - $233,213
-4,058 Reduced 0.25%
1,630,037 $93 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $78.5 Million - $87.7 Million
1,634,095
1,634,095 $87.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.